148 related articles for article (PubMed ID: 33405176)
21. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
[TBL] [Abstract][Full Text] [Related]
22. A fluorescent-based high-throughput screening assay for small molecules that inhibit the interaction of MdmX with p53.
Tsuganezawa K; Nakagawa Y; Kato M; Taruya S; Takahashi F; Endoh M; Utata R; Mori M; Ogawa N; Honma T; Yokoyama S; Hashizume Y; Aoki M; Kasai T; Kigawa T; Kojima H; Okabe T; Nagano T; Tanaka A
J Biomol Screen; 2013 Feb; 18(2):191-8. PubMed ID: 22989451
[TBL] [Abstract][Full Text] [Related]
23. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
24. A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance.
Zeng X; Montoute M; Bee TW; Lin H; Kallal LA; Liu Y; Agarwal P; Wang D; Lu Q; Morrow D; Pope AJ; Wu Z
J Biomol Screen; 2016 Mar; 21(3):260-8. PubMed ID: 26656867
[TBL] [Abstract][Full Text] [Related]
25. Angler Peptides: Macrocyclic Conjugates Inhibit p53:MDM2/X Interactions and Activate Apoptosis in Cancer Cells.
Philippe GJ; Mittermeier A; Lawrence N; Huang YH; Condon ND; Loewer A; Craik DJ; Henriques ST
ACS Chem Biol; 2021 Feb; 16(2):414-428. PubMed ID: 33533253
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
[TBL] [Abstract][Full Text] [Related]
27. A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
Chen C; Lan MS
Cell Signal; 2020 Dec; 76():109785. PubMed ID: 32966884
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms.
Axelrod M; Gordon VL; Conaway M; Tarcsafalvi A; Neitzke DJ; Gioeli D; Weber MJ
Oncotarget; 2013 Apr; 4(4):622-35. PubMed ID: 23599172
[TBL] [Abstract][Full Text] [Related]
29. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.
Jansson KH; Tucker JB; Stahl LE; Simmons JK; Fuller C; Beshiri ML; Agarwal S; Fang L; Hynes PG; Alilin AN; Lake R; Abbey YC; Cawley J; Tice CM; Yin J; McKnight C; Klummp-Thomas C; Zhang X; Guha R; Hoover S; Simpson RM; Nguyen HM; Corey E; Thomas CJ; Proia DA; Kelly K
Sci Rep; 2018 Nov; 8(1):17239. PubMed ID: 30467317
[TBL] [Abstract][Full Text] [Related]
30. NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.
Ramesh V; Selvarasu K; Pandian J; Myilsamy S; Shanmugasundaram C; Ganesan K
Cell Oncol (Dordr); 2016 Dec; 39(6):523-536. PubMed ID: 27562587
[TBL] [Abstract][Full Text] [Related]
31. YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.
Bhaskar Rao D; Panneerpandian P; Balakrishnan K; Ganesan K
J Cell Commun Signal; 2021 Jun; 15(2):251-267. PubMed ID: 33620645
[TBL] [Abstract][Full Text] [Related]
32. Cell-based methods for the identification of MYC-inhibitory small molecules.
Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA
Methods Mol Biol; 2013; 1012():255-64. PubMed ID: 24006071
[TBL] [Abstract][Full Text] [Related]
33. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
34. The gender of cell lines matters when screening for novel anti-cancer drugs.
Nunes LM; Robles-Escajeda E; Santiago-Vazquez Y; Ortega NM; Lema C; Muro A; Almodovar G; Das U; Das S; Dimmock JR; Aguilera RJ; Varela-Ramirez A
AAPS J; 2014 Jul; 16(4):872-4. PubMed ID: 24875051
[TBL] [Abstract][Full Text] [Related]
35. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
36. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
37. Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform.
Li S; Hsu CW; Sakamuru S; Zou C; Huang R; Xia M
SLAS Technol; 2018 Jun; 23(3):217-225. PubMed ID: 28922619
[TBL] [Abstract][Full Text] [Related]
38. Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors.
Brewitz L; Tumber A; Pfeffer I; McDonough MA; Schofield CJ
Sci Rep; 2020 May; 10(1):8650. PubMed ID: 32457455
[TBL] [Abstract][Full Text] [Related]
39. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing Sarcoma.
Sun H; Lin DC; Cao Q; Pang B; Gae DD; Lee VKM; Lim HJ; Doan N; Said JW; Gery S; Chow M; Mayakonda A; Forscher C; Tyner JW; Koeffler HP
Clin Cancer Res; 2017 Aug; 23(15):4376-4387. PubMed ID: 28336564
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
